Ultralife Corporation Reports First Quarter Results [Yahoo! Finance]
Ultralife Corporation (ULBI)
US:NASDAQ Investor Relations:
investor.ultralifecorporation.com/investor-relations
Company Research
Source: Yahoo! Finance
Sales of $41.9 million representing a 31.4% year-over-year increase, including 54.7% growth in medical market sales Gross profit of $11.5 million, or 27.4% of revenue, compared to $7.4 million, or 23.3% of revenue for the 2023 first quarter Operating income of $4.1 million versus breakeven for the 2023 first quarter GAAP EPS of $0.18 compared to a loss of $0.02 for the 2023 first quarter Adjusted EBITDA of $5.2 million, a four-fold gain compared to $1.2 million last year Backlog of $97.4 million exiting the 2024 first quarter “Ultralife's strong first quarter results are a testament to the teamwork and success to date of our gross margin improvement initiatives and continued demand in our core products, particularly from our government/defense and medical customers,” said Mike Manna, President and Chief Executive Officer. “With the current healthy backlog and new product commercialization, we are prepared to capture additional organic growth opportunities, while we contin
Show less
Read more
Impact Snapshot
Event Time:
ULBI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ULBI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ULBI alerts
High impacting Ultralife Corporation news events
Weekly update
A roundup of the hottest topics
ULBI
News
- Ultralife Co. (NASDAQ: ULBI) had its price target raised by analysts at Benchmark Co. from $13.00 to $14.00. They now have a "buy" rating on the stock.MarketBeat
- Ultralife Co. (NASDAQ: ULBI) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Ultralife Co. (NASDAQ: ULBI) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Ultralife Corporation (NASDAQ:ULBI) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Ultralife Corporation Reports First Quarter ResultsGlobeNewswire
ULBI
Sec Filings
- 6/7/24 - Form 4
- 5/30/24 - Form SD
- 5/29/24 - Form DEF
- ULBI's page on the SEC website